TD Cowen analyst Phil Nadeau maintained a Buy rating on Rhythm Pharmaceuticals (RYTM – Research Report) today. The company’s shares opened ...

TD Cowen analyst Marc Frahm maintained a Buy rating on Repare Therapeutics (RPTX – Research Report) today. The company’s shares closed last ...

On Monday, Jan. 7, Michael Lavery at Piper Sandler initiated coverage of the beverage giant, with an overweight rating and a ...

Fintel reports that on January 8, 2025, TD Cowen downgraded their outlook for Leidos Holdings (NYSE:LDOS) from Buy to Hold.

Fintel reports that on January 8, 2025, TD Cowen upgraded their outlook for Coca-Cola (NYSE:KO) from Hold to Buy. Analyst ...

Shares of American Airlines surged Monday after brokerages Jefferies and TD Cowen upgraded and raised their price targets on ...

“Two-thousand-twenty-four was a tough year for staples stocks, and 2025 is shaping up to be even tougher,” says TD Cowen ...

El Lilly’s blockbuster weight-loss drug Zepbound is now eligible for coverage under Medicare prescription drug plans, when ...

When the BIOSECURE Act hit a setback and missed the chance of becoming law in 2024, the deceleration of the draft legislation ...

TD Cowen has recently reiterated Marathon Petroleum Corp (MPC) stock to Buy rating, as announced on December 10, 2024, according to Finviz. Earlier, on November 6, 2024, TD Cowen had reiterated the ...

The upgrades come as American Airlines has seen a substantial improvement in its domestic market, with competitors making ...

American Airlines Group Inc.'s stock gained 3.2% on Monday, after a slew of upgrades that acknowledged the company is coming out of transitory 2024 challenges to a better backdrop in 2025. The big ...